Look forward to the journey ahead with a once-monthly treatment that lowers and keeps urinary oxalate levels under control.
Find out how Rivfloza® helps prevent extra oxalate from being produced in people with PH1.
The only selfa- or caregivera,b-administered PH1 treatment.
aAfter proper training by a health care professional for patients 12 years of age and up.
bFor children 9 to 11 years of age (after training and guidance from a health care professional for the single-dose vial).
Our NovoCare® patient support team can provide more information about Rivfloza® and how to get started on treatment.
If you would like to receive more information, including
the latest updates, on Rivfloza®, register today.